FIELD: medicine, transfusiology.
SUBSTANCE: invention can be used to mobilize blood from the depot during acute blood loss. The use of polymerized hemoglobin in the form of a solution for infusion prepared from a lyophilisate is proposed, where the polymerized hemoglobin is hemoglobin polymerized by glutaraldehyde, obtained from cattle, with a molecular weight in the range of 192,000-320,000 Da, where the lyophilisate contains at least 90% of polymerized hemoglobin, as a means that has the properties of mobilizing blood cells from blood-depositing organs in case of acute blood loss. Polymerized hemoglobin is administered to patients in a dose of 1 to 12.6 g per day.
EFFECT: use of the invention makes it possible to restore hemodynamic and hematological parameters in the first hours after hemorrhagic shock with low doses of polymerized hemoglobin due to its properties of mobilizing blood cells from blood depositing organs.
2 cl, 8 tbl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BLOOD SUBSTITUTE WITH FUNCTION OF OXYGEN TRANSFER, PHARMACEUTICAL COMPOSITION (VERSIONS) | 2008 |
|
RU2361608C1 |
USE OF POLYMERIZED HEMOGLOBIN FOR INCREASING EFFICIENCY OF MALIGNANT TUMOR CHEMOTHERAPY | 2021 |
|
RU2789607C1 |
BLOOD SUBSTITUTE AS OXYGEN TRANSPORTER, COMPOSITION FOR ITS PREPARING AND METHOD OF POLYMERIC MODIFIED HEMOGLOBIN PREPARING | 1999 |
|
RU2162707C2 |
INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
ARTIFICIAL PLASMA EXTENDER | 2014 |
|
RU2582219C2 |
WATER-SOLUBLE POLYMERIC ANTIOXIDANT, PLASMA SUBSTITUTE WITH ANTIOXIDANT AND ANTIRADICAL ACTIVITY (VARIANTS) AND METHOD FOR MAINTENANCE ARTERIAL PRESSURE LEVEL AND ANTIOXIDANT PROTECTION PROCESS IN BODY IN ACUTE BLOOD LOSS | 2004 |
|
RU2273483C2 |
POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
POLYFUNCTIONAL BLOOD SUBSTITUTE | 2003 |
|
RU2245150C1 |
METHOD FOR PREVENTION OF SEVERE COMPLICATIONS ACCOMPANYING SURGICAL MANAGEMENT OF MASSIVE AND SUBMASSIVE BLOOD LOSS WITH CONTINUOUS HAEMORRHAGES | 2011 |
|
RU2475234C2 |
Authors
Dates
2024-01-11—Published
2021-08-19—Filed